Biblio Discovery — Demo Discovery Service

60 results for "Mor, Adam"

Showing 41–60 · 0.21 seconds · RSS

  1. Journal Article Full text

    EF Hand domain family member D2 is required for T cell cytotoxicity

    Peled, Michael; Dragovich, Matthew A.; Adam, Kieran et al.

    J Immunol · 2018 · English · PubMed Central

    Programmed cell death-1 (PD-1) is a major co-inhibitory receptor and a member of the immunological synapse (IS). To uncover proteins that regulate PD-1 recruitment to the IS, we searched for cytoskeleton-related proteins that also interact with PD-1 using affinity purification mass spectrometry…

  2. Journal Article Full text

    PLCε1 regulates SDF-1α–induced lymphocyte adhesion and migration to sites of inflammation

    Strazza, Marianne; Azoulay-Alfaguter, Inbar; Peled, Michael et al.

    Proc Natl Acad Sci U S A · 2017 · English · PubMed Central

    Regulation of integrins is critical for lymphocyte adhesion to endothelium and migration throughout the body. Inside-out signaling to integrins is mediated by the small GTPase Ras-proximate-1 (Rap1). Using an RNA-mediated interference screen, we identified phospholipase Cε 1 (PLCε1) as a crucial…

  3. Journal Article Full text

    The tyrosine phosphatase SHP-1 promotes T cell adhesion by activating the adaptor protein CrkII in the immunological synapse

    Azoulay-Alfaguter, Inbar; Strazza, Marianne; Peled, Michael et al.

    Sci Signal · 2017 · English · PubMed Central

    The adaptor protein CrkII regulates T cell adhesion by recruiting the guanine nucleotide exchange factor C3G, an activator of Rap1. Subsequently, Rap1 stimulates the integrin LFA-1, which leads to T cell adhesion and interaction with antigen-presenting cells (APCs). The adhesion of T cells to APCs…

  4. Journal Article Full text

    PD-1 signaling uncovers a pathogenic subset of T cells in inflammatory arthritis

    Straube, Johanna; Bukhari, Shoiab; Lerrer, Shalom et al.

    Arthritis Res Ther · 2024 · English · PubMed Central

    BACKGROUND: PD-1 is an immune checkpoint on T cells, and interventions to block this receptor result in T cell activation and enhanced immune response to tumors and pathogens. Reciprocally, despite a decade of research, approaches to treat autoimmunity with PD-1 agonists have only had limited…

  5. Journal Article Full text

    Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity

    Hu, Xizi; Bukhari, Shoiab M; Tymm, Carly et al.

    J Immunother Cancer · 2024 · English · PubMed Central

    BACKGROUND: Immune checkpoint inhibitors (ICIs) have improved outcomes and extended patient survival in several tumor types. However, ICIs often induce immune-related adverse events (irAEs) that warrant therapy cessation, thereby limiting the overall effectiveness of this class of therapeutic…

  6. Journal Article Full text

    SAP-expressing T peripheral helper cells identify systemic lupus erythematosus patients with lupus nephritis

    Gartshteyn, Yevgeniya; Geraldino-Pardilla, Laura; Khalili, Leila et al.

    Front Immunol · 2024 · English · PubMed Central

    INTRODUCTION: T follicular (TFH) and peripheral helper (TPH) cells have been increasingly recognized as a pathogenic subset of CD4 T cells in systemic lupus erythematosus (SLE). The SLAM Associated Protein (SAP) regulates TFH and TPH function by binding to the co-stimulatory signaling lymphocyte…

  7. Journal Article Full text

    Rap1-interacting adapter molecule (RIAM) associates with the plasma membrane via a proximity detector

    Wynne, Joseph P.; Wu, Jinhua; Su, Wenjuan et al.

    J Cell Biol · 2012 · English · PubMed Central

    Adaptive immunity depends on lymphocyte adhesion that is mediated by the integrin lymphocyte functional antigen 1 (LFA-1). The small guanosine triphosphatase Rap1 regulates LFA-1 adhesiveness through one of its effectors, Rap1-interacting adapter molecule (RIAM). We show that RIAM was recruited to…

  8. Journal Article Full text

    Osteoarthritis increases the risk of inflammatory arthritis due to immune checkpoint inhibitors associated with tissue-resident memory T cells

    Paiola, Matthieu; Portnoy, Daniel M; Hao, Luke Yi et al.

    J Immunother Cancer · 2025 · English · PubMed Central

    OBJECTIVE: Immune checkpoint inhibitors (ICIs) have significantly advanced cancer treatment, but they can also lead to immune-related adverse events (irAEs), including inflammatory arthritis. Understanding the risk factors and underlying mechanisms of irAE pathogenesis is crucial for optimal…

  9. Journal Article Full text

    The structural features that distinguish PD-L2 from PD-L1 emerged in placental mammals

    Philips, Elliot A.; Garcia-España, Antonio; Tocheva, Anna S. et al.

    J Biol Chem · 2019 · English · PubMed Central

    Programmed cell death protein 1 (PD-1) is an inhibitory receptor on T lymphocytes that is critical for modulating adaptive immunity. As such, it has been successfully exploited for cancer immunotherapy. Programmed death ligand 1 (PD-L1) and PD-L2 are ligands for PD-1; the former is ubiquitously…

  10. Journal Article Full text

    Platelet Bound Complement Split Product (PC4d) is a Marker of Platelet Activation and Arterial Vascular Events in Systemic Lupus Erythematosus

    Gartshteyn, Yevgeniya; Mor, Adam; Shimbo, Daichi et al.

    Clin Immunol · 2021 · English · PubMed Central

    Platelet-bound complement activation products (PC4d) are associated with thrombosis in Systemic Lupus Erythematosus (SLE). This study investigated the effect of PC4d on platelet function, as a mechanistic link to arterial thrombosis. In a cohort of 150 SLE patients, 13 events had occurred within…

  11. Journal Article Full text

    Proteasomal adaptation to environmental stress links resistance to proteotoxicity with longevity in Caenorhabditis elegans

    Yun, Chi; Stanhill, Ariel; Yang, Yun et al.

    Proc Natl Acad Sci U S A · 2008 · English · PubMed Central

    The burden of protein misfolding is believed to contribute to aging. However, the links between adaptations to conditions associated with protein misfolding and resistance to the time-dependent attrition of cellular function remain poorly understood. We report that worms lacking aip-1, a homologue…

  12. Journal Article Full text

    Mesencephalic astrocyte-derived neurotrophic factor is secreted from interferon-γ–activated tumor cells through ER calcium depletion

    Peled, Michael; Bar-Lev, Tali H.; Talalai, Efrosiniia et al.

    PLoS One · 2021 · English · PubMed Central

    The most successful immunotherapeutic agents are blocking antibodies to either programmed cell death-1 (PD-1), an inhibitory receptor expressed on T lymphocytes, or to its ligand, programmed cell death-ligand 1 (PD-L1). Nevertheless, many patients do not respond, and additional approaches…

  13. Journal Article Full text

    Hydrophobic complementarity-determining region 3 (CDR3) sequences elucidate the cardiotoxic effects of immune checkpoint inhibitors

    Bukhari, Shoiab; Mohindra, Rajat; Paiola, Matthieu et al.

    Res Sq · 2025 · English · PubMed Central

    Immune checkpoint inhibitors (ICIs) have significantly changed cancer treatment, demonstrating strong efficacy across multiple cancers. However, their use also carries the risk of serious immune-related side effects (irAEs), especially cardiotoxicity. To understand how these adverse effects occur…

  14. Journal Article Full text

    Exclusion of PD-1 from the immune synapse: A novel strategy to modulate T cell function

    Hao, Luke Yi; Lerrer, Shalom; Paiola, Matthieu et al.

    Mol Ther Oncol · 2024 · English · PubMed Central

    Targeting immune checkpoint receptors on T cells is a common cancer treatment strategy. Frequently, this is accomplished through antibodies targeting the ligand of inhibitory co-receptors. Blocking the immune checkpoint PD-1 binding to its ligands PD-L1 and PD-L2 prevents downstream signaling and…

  15. Journal Article Full text

    Rap1 and its effector RIAM are required for lymphocyte trafficking

    Su, Wenjuan; Wynne, Joseph; Pinheiro, Elaine M. et al.

    Blood · 2015 · English · PubMed Central

    Regulation of integrins is critical for lymphocyte adhesion to endothelium and trafficking through secondary lymphoid organs. Inside-out signaling to integrins is mediated by the small GTPase Rap1. Two effectors of Rap1 regulate integrins, RapL and Rap1 interacting adaptor molecule (RIAM). Using…

  16. Journal Article Full text

    PAG orchestrates T cell immune synapse function by binding to actin

    Moore, Emily K.; Strazza, Marianne; Hu, Xizi et al.

    bioRxiv · 2024 · English · PubMed Central

    Many immunotherapies impact T cell function by impacting the immune synapse. While immunotherapy is extremely successful in some patients, in many others, it fails to help or causes complications, including immune-related adverse events. Phosphoprotein Associated with Glycosphingolipid Rich…

  17. Journal Article Full text

    Quantitative phosphoproteomic analysis reveals involvement of PD-1 in multiple T cell functions

    Tocheva, Anna S.; Peled, Michael; Strazza, Marianne et al.

    J Biol Chem · 2021 · English · PubMed Central

    Programmed cell death protein 1 (PD-1) is a critical inhibitory receptor that limits excessive T cell responses. Cancer cells have evolved to evade these immunoregulatory mechanisms by upregulating PD-1 ligands and preventing T cell–mediated anti-tumor responses. Consequently, therapeutic blockade…

  18. Journal Article Full text

    Affinity purification mass spectrometry analysis of PD-1 uncovers SAP as a new checkpoint inhibitor

    Peled, Michael; Tocheva, Anna S.; Sandigursky, Sabina et al.

    Proc Natl Acad Sci U S A · 2017 · English · PubMed Central

    Programmed cell death-1 (PD-1) is an essential inhibitory receptor in T cells. Antibodies targeting PD-1 elicit durable clinical responses in patients with multiple tumor indications. Nevertheless, a significant proportion of patients do not respond to anti–PD-1 treatment, and a better…

  19. Journal Article Full text

    Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors

    Bukhari, Shoiab; Henick, Brian S.; Winchester, Robert J. et al.

    Cell Rep Med · 2022 · English · PubMed Central

    PD-1 is an inhibitory receptor in T cells, and antibodies that block its interaction with ligands augment anti-tumor immune responses. The clinical potential of these agents is limited by the fact that half of all patients develop immune-related adverse events (irAEs). To generate insights into the…

  20. Journal Article Full text

    Transmembrane domain–driven PD-1 dimers mediate T cell inhibition

    Philips, Elliot A.; Liu, Jia; Kvalvaag, Audun et al.

    Sci Immunol · 2024 · English · PubMed Central

    Programmed cell death-1 (PD-1) is a potent immune checkpoint receptor on T lymphocytes. Upon engagement by its ligands, PD-L1 or PD-L2, PD-1 inhibits T cell activation and can promote immune tolerance. Antagonism of PD-1 signaling has proven effective in cancer immunotherapy, and conversely…